Migrating partial seizures in infancy (MPSI) are an age-specific epilepsy syndrome characterized by migrating focal seizures, which are intractable to various antiepileptic drugs and cause severe developmental delay. We report a case of MPSI with heterozygous missense mutation in KCNT1, which was successfully managed by ketogenic diet. At age 2 months, the patient developed epilepsy initially manifesting focal seizures with eye deviation and apnea, then evolving to secondarily generalized clonic convulsion. Various antiepileptic drugs including phenytoin, valproic acid, zonisamide, clobazam, levetiracetam, vitamin B6, and carbamazepine were not effective, but high-dose phenobarbital allowed discontinuation of midazolam infusion. Ictal scalp electroencephalogram showed migrating focal seizures. MPSI was suspected and she was transferred to our hospital for further treatment. Potassium bromide (KBr) was partially effective, but the effect was transient. High-dose KBr caused severe adverse effects such as over-sedation and hypercapnia, with no further effects on the seizures. At age 9 months, we started a ketogenic diet, which improved seizure frequency and severity without obvious adverse effects, allowing her to be discharged from hospital. Ketogenic diet should be tried in patients with MPSI unresponsive to antiepileptic drugs. In MPSI, the difference in treatment response in patients with and those without KCNT1 mutation remains unknown. Accumulation of case reports would contribute to establish effective treatment options for MPSI.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Brain and Development
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Migrating partial seizures in infancy: a malignant disorder with developmental arrest.Epilepsia. 1995; 36: 1017-1024
- Migrating partial seizures of infancy. Expansion of the electroclinical, radiological and pathological disease spectrum.Brain. 2013; 136: 1578-1591
- Potassium bromide for treatment of malignant migrating partial seizures in infancy.Pediatr Neurol. 2013; 49: 355-357
- Successful control with bromide of two patients with malignant migrating partial seizures in infancy.Brain Dev. 2000; 22: 56-59
- Temporal lobe dual pathology in malignant migrating partial seizures in infancy.Epileptic Disord. 2007; 9: 145-148
- Bromoderma in a patient with migrating partial seizures in infancy.Epilepsy Res. 2010; 91: 283-288
- The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.Epileptic Disord. 2011; 13: 22-26
- Effects of acetazolamide on epileptic apnea in migrating partial seizures in infancy.Epilepsy Res. 2011; 96: 185-189
- Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases.Epileptic Disord. 2011; 13: 18-21
- Epilepsy of infancy with migrating focal seizures: three patients treated with the ketogenic diet.Epileptic Disord. 2015; 17: 194-197
Sugai K. Migrating partial seizures in infancy. General overview and study report which was conducted by Health Labour Sciences Research Grant at 2013 for the rare and intractable epilepsy. Edited by Otsuki T; 2014: 15–17. [published in Japanese].
- Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies.J Neurochem. 1996; 67: 2325-2334
- Targeted treatment of migrating partial seizures of infancy with quinidine.Ann Neurol. 2014; 76: 457-461
Published online: January 11, 2016
Accepted: December 23, 2015
Received in revised form: November 25, 2015
Received: July 27, 2015
© 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.